About Ranjit Bindra
Ranjit Bindra is a director at Alphina Therapeutics.
Ranjit Bindra first appears on SEC filings in 2021.
Experience
This experience comes from Ranjit Bindra's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ranjit Bindra in the role, so the role may have started earlier or lasted longer.
MB
Modifi Bio Current
Co-Founder
2021 – Present
Alphina Therapeutics, Inc. Current
Co-Founder (2020 – Present)
Director
2020 – Present · New Haven, CT
Develops cancer drugs and a patient-selection test for people with solid tumors.
BT
B3 Therapeutics Current
Co-Founder
2020 – Present
CT
Cybrexa Therapeutics Current
Co-Founder
2017 – Present
YM
Yale School of Medicine Current
Vice Chair for Basic and Translational Research
2012 – Present
YM
Yale University School of Medicine
Professor
2000 – 2021
MS
MSKCC
Physician-Scientist, Radiation Oncology
2008 – 2012
HL
Helix Therapeutics, LLC
Co-Founder
2005 – 2012
Key Colleagues at Startups
The people Ranjit Bindra works with at each company, as listed on that company's latest Form D.
Alphina Therapeutics, Inc. · Form D, Mar 16, 2026
BF
Barbara Fox
Chair
CC
Colleen Cuffaro
Member of Alphina's Board
NG
Nicholas Galli
Chief Executive Officer and director
KR
Kevin Rakin
Director
MC
Matthew Cohen
Director